Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Aquestive Therapeutics | AQST | Oct 16, 2024 | 4.93 | +0.82 |
Aramark | ARMK | Oct 16, 2024 | 39.40 | +1.00 |
ARB IOT Group | ARBB | Oct 16, 2024 | 0.31 | +16.97 |
Arbe Robotics | ARBE | Oct 16, 2024 | 2.00 | -0.99 |
Arbor Realty Trust | ABR | Oct 16, 2024 | 15.29 | +0.79 |
Arbor Realty Trust D Pref | ABR-D | Oct 16, 2024 | 19.52 | -0.56 |
Arbor Realty Trust E Pref | ABR-E | Oct 16, 2024 | 19.77 | -0.70 |
Arbor Realty Trust F Pref | ABR-F | Oct 16, 2024 | 19.61 | +0.31 |
Arbutus Biopharma | ABUS | Oct 16, 2024 | 4.20 | +2.19 |
ARC Document Solutions | ARC | Oct 16, 2024 | 3.42 | +0.59 |
Arcadia Biosciences | RKDA | Oct 16, 2024 | 2.78 | -1.42 |
Arcadium Lithium | ALTM | Oct 16, 2024 | 5.53 | 0.00 |
ArcBest | ARCB | Oct 16, 2024 | 106.31 | +1.42 |
Arcellx | ACLX | Oct 16, 2024 | 93.00 | +3.44 |
Arcelor Mittal ADR | MT | Oct 16, 2024 | 24.05 | +1.14 |
Arch Capital F Pref | ACGLO | Oct 16, 2024 | 23.60 | +0.79 |
Arch Capital G | ACGLN | Oct 16, 2024 | 20.70 | +0.05 |
Arch Capital Group | ACGL | Oct 16, 2024 | 107.47 | -0.55 |
Arch Resources A | ARCH | Oct 16, 2024 | 145.18 | +1.57 |
Archer Aviation A | ACHR | Oct 16, 2024 | 3.19 | +2.57 |
Archer Daniels Midland | ADM | Oct 16, 2024 | 58.29 | +1.08 |
Archrock | AROC | Oct 16, 2024 | 21.47 | +2.19 |
Arcos Dorados | ARCO | Oct 16, 2024 | 9.71 | +1.15 |
Arcosa | ACA | Oct 16, 2024 | 96.52 | +2.07 |
Arcturus Therapeutics | ARCT | Oct 16, 2024 | 20.63 | -1.62 |
Arcus Biosciences | RCUS | Oct 16, 2024 | 17.86 | +0.45 |
Arcutis Biotherapeutics | ARQT | Oct 16, 2024 | 9.72 | +3.96 |
Ardagh Metal Packaging | AMBP | Oct 16, 2024 | 3.97 | +0.25 |
Ardelyx | ARDX | Oct 16, 2024 | 5.85 | -2.01 |
Ardent Health Partners | ARDT | Oct 16, 2024 | 20.19 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.